6 research outputs found

    Results of the BiPo-1 prototype for radiopurity measurements for the SuperNEMO double beta decay source foils

    Get PDF
    The development of BiPo detectors is dedicated to the measurement of extremely high radiopurity in 208^{208}Tl and 214^{214}Bi for the SuperNEMO double beta decay source foils. A modular prototype, called BiPo-1, with 0.8 m2m^2 of sensitive surface area, has been running in the Modane Underground Laboratory since February, 2008. The goal of BiPo-1 is to measure the different components of the background and in particular the surface radiopurity of the plastic scintillators that make up the detector. The first phase of data collection has been dedicated to the measurement of the radiopurity in 208^{208}Tl. After more than one year of background measurement, a surface activity of the scintillators of A\mathcal{A}(208^{208}Tl) == 1.5 μ\muBq/m2^2 is reported here. Given this level of background, a larger BiPo detector having 12 m2^2 of active surface area, is able to qualify the radiopurity of the SuperNEMO selenium double beta decay foils with the required sensitivity of A\mathcal{A}(208^{208}Tl) << 2 μ\muBq/kg (90% C.L.) with a six month measurement.Comment: 24 pages, submitted to N.I.M.

    Cytopathic effects of the cytomegalovirus-encoded apoptosis inhibitory protein vMIA.

    No full text
    Replication of human cytomegalovirus (CMV) requires the expression of the viral mitochondria-localized inhibitor of apoptosis (vMIA). vMIA inhibits apoptosis by recruiting Bax to mitochondria, resulting in its neutralization. We show that vMIA decreases cell size, reduces actin polymerization, and induces cell rounding. As compared with vMIA-expressing CMV, vMIA-deficient CMV, which replicates in fibroblasts expressing the adenoviral apoptosis suppressor E1B19K, induces less cytopathic effects. These vMIA effects can be separated from its cell death-inhibitory function because vMIA modulates cellular morphology in Bax-deficient cells. Expression of vMIA coincided with a reduction in the cellular adenosine triphosphate (ATP) level. vMIA selectively inhibited one component of the ATP synthasome, namely, the mitochondrial phosphate carrier. Exposure of cells to inhibitors of oxidative phosphorylation produced similar effects, such as an ATP level reduced by 30%, smaller cell size, and deficient actin polymerization. Similarly, knockdown of the phosphate carrier reduced cell size. Our data suggest that the cytopathic effect of CMV can be explained by vMIA effects on mitochondrial bioenergetics

    Anti-Oxidant Drugs: Novelties and Clinical Implications in Cerebellar Ataxias

    No full text
    corecore